Ekso Bionics raises $3.2M net in registered direct offering of 769,490 shares at $4.81

EKSO BIONICS HOLDINGS, INC.

Sold 769,490 shares at $4.81 per share to institutional investors; net proceeds ~$3.2M.
Closing expected on or about October 30, 2025, subject to customary conditions.
Proceeds for general corporate purposes: R&D, SG&A, and working capital.
Issued placement agent warrant to Lake Street Capital Markets for 15,389 shares at $4.81.
Offering conducted under existing effective shelf registration statement (File No. 333-272607).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.